Skip to content
Search jobs inside your AI agent. Claude, ChatGPT, Claude Code, Codex, Gemini, Cursor and Grok
Connect

ReCode Therapeutics

ReCode Therapeutics is pioneering the next generation of genetic medicines through advanced delivery systems, specifically targeting rare genetic diseases.

biotechpharmaceuticals

Correct ReCode Therapeutics

ReCode Therapeutics is…

Company facts

Growth-stage
Founded
2015
Employees
105
Headquarters
United States
CEO
Shehnaaz Suliman

About

ReCode Therapeutics is at the forefront of revolutionizing genetic medicines through unparalleled delivery systems. The company’s innovative platform pioneers targeted delivery technologies that empower mRNA therapeutics and gene correction for previously untreatable genetic diseases, including primary ciliary dyskinesia and cystic fibrosis. ReCode's SELECTIVE ORGAN TARGETING (SORT) lipid nanoparticle (LNP) technology represents a breakthrough in the delivery of genetic therapies by allowing precise targeting beyond the liver, thus opening unprecedented possibilities for treating rare disorders. The foundation of ReCode's pioneering approach is rooted in unconventional thinking and scientific bravery, as seen in the work of co-founder Professor Daniel J. Siegwart, Ph.D. With over 20 years of industry limitation in the understanding of lipid nanoparticles, ReCode emerged to change this landscape by advancing how genetic medicines can be delivered effectively. Engaging in partnerships and collaborations with esteemed academic institutions and organizations, ReCode is focused on growing its clinical pipeline of genetic medicines aimed at addressing critical health challenges faced by patients worldwide. Through continuous innovation, ReCode aims to reshape the future of genetic medicine and enhance the quality of life for individuals impacted by genetic diseases.

Open positions

1 job

Join Our Talent Community

Open 153d 2 years ago3 viewsFull-time2 questions
United States
Menlo Park, California

Who We Are: ReCode Therapeutics is a clinical-stage genetic medicines company using precision delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s proprietary Selective Organ Targeting…

Greenhouse